Novo Nordisk is showing, thanks to the success of oral Wegovy, that it can still challenge its biggest competitor
The delivery of low energy, high frequency pulses to the antrum (gastric electrical stimulation) is effective in the treatment of vomiting in individuals with and without diabetes, regardless of whether they had gastroparesis, as shown in a randomised, crossover study [82]
4 However, this was a diabetes trial and not a weight loss trial and at the time of the study, the maximum approved dose of semaglutide for diabetes was 1mg
employers balance costs with providing employees more value from their benefits, creating an annual healthcare enrollment process that includes more choice and guidance can accomplish both goals
In fact, some studies have even suggested the opposite
Gastrointestinal adverse effects in the tirzepatide groups were similar to those in the other SURPASS trials